Vancomycin

cystatin C ; Homo sapiens







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33496976 Correlation between vancomycin clearance and cystatin C-based glomerular filtration rate in paediatric patients. 2021 Aug 3
2 33642514 [Assessment of Renal Function and Simulation Using Serum Cystatin-C in an Elderly Patient with Uncontrollable Plasma Vancomycin Levels Due to Muscular Dystrophy: A Case Report]. 2021 1
3 33728578 Cystatin C and/or creatinine-based estimated glomerular filtration rate for prediction of vancomycin clearance in long-stay critically ill patients with persistent inflammation, immunosuppression and catabolism syndrome (PICS): a population pharmacokinetics analysis. 2021 Oct 1
4 33967770 Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates. 2021 1
5 31463971 Development and comparison of population pharmacokinetic models of vancomycin in neurosurgical patients based on two different renal function markers. 2020 Feb 1
6 31541402 Comparison of the Predictive Performance Between Cystatin C and Serum Creatinine by Vancomycin via a Population Pharmacokinetic Models: A Prospective Study in a Chinese Population. 2020 Feb 5
7 32304024 A Population Pharmacokinetics Model for Vancomycin Dosage Optimization Based on Serum Cystatin C. 2020 Aug 6
8 32843769 Successful Vancomycin Dose Adjustment in a Sepsis patient with Bacterial Meningitis Using Cystatin C. 2020 Aug 3
9 32868529 Cystatin C is ready for clinical use. 2020 Nov 1
10 32947559 Effect of Cystatin C on Vancomycin Clearance Estimation in Critically Ill Children Using a Population Pharmacokinetic Modeling Approach. 2020 Dec 2
11 32959542 A Meta-Analysis on the Performance of Cystatin C- versus Creatinine-based eGFR Equations in Predicting Vancomycin Clearance. 2020 Sep 21 4
12 33106257 Prediction of Vancomycin Levels Using Cystatin C in Overweight and Obese Patients: a Retrospective Cohort Study of Hospitalized Patients. 2020 Dec 16 4
13 30873627 A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function. 2019 Jun 4
14 28131530 Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project. 2017 May 2
15 26692877 Usefulness of serum cystatin C to determine the dose of vancomycin in neonate. 2015 Nov 2
16 24887089 Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: a cohort study. 2014 May 29 2
17 25222855 Comparison of equations with estimate renal function to predict serum vancomycin concentration in patients with spinal cord injury--does the use of cystatin C improve accuracy? 2014 Oct 2
18 23195915 Estimation of safe and effective dose of vancomycin in MRSA-infected patients using serum cystatin C concentrations. 2013 Mar 6
19 23341711 Serum cystatin C is a major predictor of vancomycin clearance in a population pharmacokinetic analysis of patients with normal serum creatinine concentrations. 2013 Jan 5
20 19933799 Population pharmacokinetic analysis of vancomycin using serum cystatin C as a marker of renal function. 2010 Feb 1
21 20636878 Usefulness of serum cystatin C to determine the dose of vancomycin in critically ill patients. 2010 Jul 1
22 20863668 Clearance of vancomycin during continuous infusion in Intensive Care Unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. 2010 Dec 1
23 17336280 Serum cystatin C as a better marker of vancomycin clearance than serum creatinine in elderly patients. 2007 Apr 3
24 17417082 Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function. 2007 Apr 1
25 18077923 Hoek's formula, a cystatin C-based prediction formula for determining the glomerular filtration rate, is the most effective method for original adjusting the dosage of vancomycin. 2007 Nov 2
26 16778715 Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin. 2006 Jun 1
27 10472217 High-dose aprotinin with gentamicin-vancomycin antibiotic prophylaxis increases blood concentrations of creatinine and cystatin C in patients undergoing coronary artery bypass grafting. 1999 Apr 2